Surrozen (SRZN) Operating Income (2020 - 2026)

Surrozen (SRZN) recorded quarterly Operating Income of -$10.5 million in Q1 2026, up 17.27% quarter-over-quarter from -$12.6 million in Q4 2025, and down 9.48% on a YoY basis from -$11.6 million in Q1 2025.

Surrozen (SRZN) Operating Income (2020 - 2026) Analysis & Trends

Surrozen's Operating Income history runs 7 years deep, the most recent figure standing at -$10.5 million for Q1 2026.

  • In Q1 2026, Operating Income fell 9.48% year-over-year to -$10.5 million; the TTM figure through Mar 2026 stood at -$43.0 million (down 65.63% YoY), while the FY2025 annual figure was -$42.1 million, down 64.81% from the prior year.
  • Operating Income was -$10.5 million for Q1 2026 at Surrozen, up from -$12.6 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $1.2 million in Q3 2024 to a low of -$14.6 million in Q1 2023.
  • Historically, Operating Income has averaged -$9.9 million across 5 years, with a median of -$10.3 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Operating Income jumped 111.01% in 2024, then tumbled 983.52% in 2025.
  • A 5-year view of Operating Income shows it stood at -$2.2 million in 2022, then plunged by 348.32% to -$9.7 million in 2023, then gained by 11.64% to -$8.6 million in 2024, then plunged by 47.1% to -$12.6 million in 2025, then climbed by 17.27% to -$10.5 million in 2026.
  • The last three Operating Income figures came in at -$10.5 million (Q1 2026), -$12.6 million (Q4 2025), and -$10.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -32.68 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -2.97 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -19.70 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -15.76 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -3.82 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.14 Bn
9 Abivax 95.45 Bn 95.45 Bn - -65.83 Mn
10 Surrozen 239,016.67 -106.67 Mn - -10.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.46 Mn
Dec 31, 2025 -12.64 Mn
Sep 30, 2025 -10.89 Mn
Jun 30, 2025 -9.02 Mn
Mar 31, 2025 -9.55 Mn
Dec 31, 2024 -8.59 Mn
Sep 30, 2024 1.23 Mn
Jun 30, 2024 -9.05 Mn
Mar 31, 2024 -9.13 Mn
Dec 31, 2023 -9.72 Mn
Sep 30, 2023 -11.19 Mn
Jun 30, 2023 -10.28 Mn
Mar 31, 2023 -14.59 Mn
Dec 31, 2022 -2.17 Mn
Sep 30, 2022 -13.61 Mn
Jun 30, 2022 -14.07 Mn
Mar 31, 2022 -14.49 Mn
Dec 31, 2021 -15.00 Mn
Sep 30, 2021 -13.71 Mn
Jun 30, 2021 -12.66 Mn